GINS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.025400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.219600E-01
Normal-vs-Stage2
4.422600E-01
Normal-vs-Stage3
7.104000E-01
Normal-vs-Stage4
8.217200E-01
Stage1-vs-Stage2
5.880000E-01
Stage1-vs-Stage3
5.253000E-01
Stage1-vs-Stage4
9.120200E-01
Stage2-vs-Stage3
2.503800E-01
Stage2-vs-Stage4
5.566600E-01
Stage3-vs-Stage4
6.357800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.905200E-01
Normal-vs-AfricanAmerican
8.017400E-01
Normal-vs-Asian
4.768000E-01
Caucasian-vs-AfricanAmerican
1.019220E-01
Caucasian-vs-Asian
6.400800E-01
AfricanAmerican-vs-Asian
4.817800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.345000E-01
Normal-vs-Female
4.665200E-01
Male-vs-Female
2.500400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.743600E-01
Normal-vs-Age(41-60Yrs)
4.788200E-01
Normal-vs-Age(61-80Yrs)
5.265400E-01
Normal-vs-Age(81-100Yrs)
3.478000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.542200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.815000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.526000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.333000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.765600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.584200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.486800E-01
Normal-vs-Daily Drinker
4.910200E-01
Normal-vs-Weekly Drinker
5.806200E-01
Normal-vs-Occasional Drinker
3.871200E-01
Normal-vs-Social Drinker
4.129800E-01
Non Drinker-vs-Daily Drinker
9.001400E-01
Non Drinker-vs-Weekly Drinker
5.688600E-01
Non Drinker-vs-Occasional Drinker
8.538200E-01
Non Drinker-vs-Social Drinker
7.392000E-01
Daily Drinker-vs-Weekly Drinker
5.291200E-01
Daily Drinker-vs-Occasional Drinker
7.361800E-01
Daily Drinker-vs-Social Drinker
6.299400E-01
Weekly Drinker-vs-Occasional Drinker
6.267200E-01
Weekly Drinker-vs-Social Drinker
6.983800E-01
Occasional Drinker-vs-Social Drinker
8.591600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.861200E-01
Normal-vs-Grade 2
6.289200E-01
Normal-vs-Grade 3
6.608600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.236200E-02
Grade 1-vs-Grade 3
2.217700E-03
Grade 1-vs-Grade 4
5.861200E-01
Grade 2-vs-Grade 3
9.988300E-02
Grade 2-vs-Grade 4
6.289200E-01
Grade 3-vs-Grade 4
6.608600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.058600E-01
Normal-vs-NonDiabetic
4.818400E-01
Diabetic-vs-NonDiabetic
2.668600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.467600E-01
Normal-vs-NoPancreatitis
5.277600E-01
Pancreatitis-vs-NoPancreatitis
1.619160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.836000E-01
Normal-vs-N1
4.798400E-01
N0-vs-N1
7.664200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.551600E-01
Normal-vs-TP53-NonMutant
6.497000E-01
TP53-Mutant-vs-TP53-NonMutant
1.91585999999022E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
